US Needle-Free Blood Drawing Devices Market - 2025-2033

June 2025 | 62 pages | ID: U118CD4D8047EN
DataM Intelligence

US$ 1,899.00 US$ 4,350.00 -56 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
US Needle-Free Blood Drawing Devices Market reached US$ 2,259.04 Million in 2024 and is expected to reach US$ 4,078.91 Million by 2033, growing with a CAGR of 6.40% during the forecast period 2026-2033.

The US Needle-Free Blood Drawing Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A US Needle-Free Blood Drawing Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type
  • Handheld Devices*
  • Wearable Devices
By Technology
  • Venipuncture*
  • Touch-Based
By End-User
  • Hospitals*
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global US Needle-Free Blood Drawing Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Technology
2.5. Snippet by End-User

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Increasing Demand for Pain-Free Alternatives
    3.1.1.2. Rising Demand for Home-Based Healthcare
    3.1.1.3. XX
  3.1.2. Restraints
    3.1.2.1. Regulatory Challenges
    3.1.2.2. High Cost of Devices
    3.1.2.3. XX
  3.1.3. Opportunity
    3.1.3.1. Rising Health Awareness and Preventive Care
    3.1.3.2. XX

4. IMPACT ANALYSIS

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
  5.1.1. Emerging Pioneers and Prominent Players
  5.1.2. Established leaders with the largest-selling Brand
  5.1.3. Market leaders with established Product Type
5.2. CXO Perspectives
5.3. Latest Developments and Breakthroughs
5.4. Case Studies/Ongoing Research
5.5. Regulatory and Reimbursement Landscape
5.6. Porter’s Five Forces Analysis
5.7. Supply Chain Analysis
5.8. Patent Analysis
5.9. SWOT Analysis
5.10. Unmet Needs and Gaps
5.11. Recommended Strategies for Market Entry and Expansion
5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.13. Pricing Analysis and Price Dynamics
5.14. Key Opinion Leaders

6. US NEEDLE-FREE BLOOD DRAWING DEVICES MARKET, BY PRODUCT TYPE

6.1. Introduction
  6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
  6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wearable Devices

7. US NEEDLE-FREE BLOOD DRAWING DEVICES MARKET, BY TECHNOLOGY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  7.1.2. Market Attractiveness Index, By Technology
7.2. Venipuncture*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Touch-Based

8. US NEEDLE-FREE BLOOD DRAWING DEVICES MARKET, BY END-USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Diagnostic Laboratories
8.5. Others

9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Type Portfolios and Innovations
9.5. Company Benchmarking

10. COMPANY PROFILES

10.1. Becton, Dickinson and Company (BD)
  10.1.1. Company Overview
  10.1.2. Product Type Portfolio
    10.1.2.1. Product Type Description
    10.1.2.2. Product Type Key Performance Indicators (KPIs)
    10.1.2.3. Historic and Forecasted Product Type Sales
    10.1.2.4. Product Type Sales Volume
  10.1.3. Financial Overview
    10.1.3.1. Company Revenue
    10.1.3.2. Geographical Revenue Shares
    10.1.3.3. Revenue Forecasts
  10.1.4. Key Developments
    10.1.4.1. Mergers & Acquisitions
    10.1.4.2. Key Product Type Development Activities
    10.1.4.3. Regulatory Approvals, etc.
  10.1.5. SWOT Analysis
10.2. YourBio Health, Inc.
10.3. Tasso, Inc.
10.4. Romsons
10.5. AlphaBiolabs Ltd
10.6. Loop Medical SA.
10.7. Utah Medical Products, Inc.
10.8. ICU Medical, Inc.
10.9. Winnoz Technology, Inc. (*LIST NOT EXHAUSTIVE)

11. ASSUMPTIONS AND RESEARCH METHODOLOGY

11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation

12. APPENDIX

12.1. About Us and Services
12.2. Contact Us


More Publications